InvestorsHub Logo
Followers 12
Posts 2377
Boards Moderated 0
Alias Born 01/23/2006

Re: jakedogman1 post# 63395

Tuesday, 05/03/2011 11:36:14 AM

Tuesday, May 03, 2011 11:36:14 AM

Post# of 346137
TUSTIN, CA -- (Marketwire) -- 05/03/11 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies for the treatment of cancer and viral infections, today announced that it's having trouble finding it's butt with 2 hands.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News